Biosafety data as confidential business information.
Removal of confidentiality claims on biosafety data is necessary to adhere to standard scientific procedures of quality assurance, to increase transparency, to minimize impacts of conflicts of interests, and ultimately to improve public confidence in GMOs.
Guardado en:
Autor principal: | Kaare M Nielsen |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Public Library of Science (PLoS)
2013
|
Materias: | |
Acceso en línea: | https://doaj.org/article/94e9c705bfe74588872bd00c8d05debe |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Biosafety Guidelines for Handling Microorganisms in the Teaching Laboratory: Development and Rationale
por: Elizabeth A. B. Emmert
Publicado: (2013) -
Dealing with data: a case study on information and data management literacy.
por: Melissa A Haendel, et al.
Publicado: (2012) -
Biosafety Level-4 laboratories in Europe: opportunities for public health, diagnostics, and research.
por: Carla Nisii, et al.
Publicado: (2013) -
Guidelines for Biosafety in Teaching Laboratories Version 2.0: A Revised and Updated Manual for 2019
por: Jeffrey J. Byrd, et al.
Publicado: (2019) -
Synergistic stabilization of a double mutant in chymotrypsin inhibitor 2 from a library screen in E. coli
por: Louise Hamborg, et al.
Publicado: (2021)